| abstract |
The following compounds of formula (I) and their tautomers, stereoisomers, isotopes, or pharmaceutically acceptable salts thereof are disclosed: (I), Each of the variables R 1 , rings A, L, W, V, and G in the formula is defined herein. In addition, a method of treating a disease or disorder mediated by Tyro3, Axl, and/or Mer kinase with a compound of formula (I) or a tautomer, stereoisomer, isotope, or salt thereof and a pharmaceutical composition containing the same Is initiated. |